| 產(chǎn)品名稱 | Leucine-rich Alpha 2 Glycoprotein-1 (LRG1), Human Plasma | Athens Research & Technology |
| 產(chǎn)品貨號(hào) | 16-16-121807 |
| 產(chǎn)品價(jià)格 | 現(xiàn)貨詢價(jià),電話:010-67529703 |
| 產(chǎn)品規(guī)格 | size |
| 產(chǎn)品品牌 | Athens Research |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
PRODUCT NUMBER:16-16-121807Buy direct from manufacturer.
MW: 50,000 by SDS PAGE Lyophilized from 20mM Tris, 20 mM NaCl, pH 7.5
LRG1 binds cytochrome c, an initiator/amplifier of programmed cell death (apoptosis), and by binding cytochrome c, is thought to play a role in cell survival. LRG1 is a biomarker associated with several cancers, including non-small cell lung cancer, colorectal cancer, and pancreatic cancer. Recent studies have shown it is three-fold more abundant in ovarian cancer serum compared to non-cancer control serum. LRG1 levels are only moderately correlated with CA125 levels. Elevated levels of LRG1 in cerebral spinal fluid are being studied as markers for the early diagnosis of Parkinson's disease and progressive supranuclear palsy.
Purity: >=95% by SDS-PAGE. Positive reaction to anti-LRG1 on Western Blot. Prepared from plasma shown to be non reactive for HBsAg, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA approved tests.
|
| 產(chǎn)品資料 |